Wednesday, July 8, 2026

Intelligence · Clinical Development

Pipeline search results

Programs matching “healthy-volunteers” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.

Matching programs 263
Total indexed 20,548
Sponsors 1,769

Quick answer

Showing 263 pipeline programs matching "healthy-volunteers" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.

Refine search

263 results for “healthy-volunteers” Back to intelligence hub

Search results

Page 6 of 11
  1. Mobocertinib

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  2. NNC0480-0389

    Novo Nordisk A/S

    Healthy Volunteers Type 2 Diabetes

    phase 1 small molecule completed

    1 trial
  3. NRS-033

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  4. Nifedipine 60 MG Extended Release Oral Tablet

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  5. ORG-129

    Agomab Therapeutics NV

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  6. ORIC-101

    Topiloric/Uriadec

    Healthy Volunteers

    phase 1 small molecule completed

    2 trials
  7. ORKA-001

    Oruka Therapeutics

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  8. ORKA-002

    Oruka Therapeutics

    Healthy Volunteers

    phase 1 small molecule active

    1 trial
  9. PC14586

    PMV Pharmaceuticals

    Healthy Volunteers

    phase 1 small molecule completed

    3 trials
  10. PEG-IFN alfa-2a BA-free formulation (Test)

    Hoffmann-La Roche

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  11. PF-03715455

    Pfizer

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  12. PF614

    Ensysce Biosciences

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  13. PN-235

    Protagonist Therapeutics, Inc

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  14. PRX-P4-003, (-)-FCF

    Praxis Precision Medicines

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  15. PTG-300

    Protagonist Therapeutics, Inc

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  16. Placebo

    KYOWA KIRIN AUSTRALIA PTY LTD

    Healthy Volunteers Essential Hypertension

    phase 1 small molecule active

    1 trial
  17. Placebo

    Mirum Pharmaceuticals International B.V.

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  18. Placebo

    IONIS PHARMACEUTICALS INC

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  19. Placebo for Treatment A

    Agios Netherlands B.V.

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  20. Povetacicept

    Vertex Pharmaceuticals (Australia) Pty.

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  21. REGN1033

    Regeneron UK Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  22. REGN1033 (SAR391786)

    Regeneron UK Limited

    Healthy Volunteers

    phase 1 small molecule completed

    3 trials
  23. REGN1154 or placebo

    Regeneron UK Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  24. REGN1193

    Regeneron UK Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

Frequently asked questions

What is the Clinical Development Intelligence Platform?

It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.

How does this compare to Evaluate Pharma or Citeline?

Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.

Where does pipeline data come from?

Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.

Can I follow a company or program for updates?

Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.